|

TNFi (Tumor Necrosis Factor inhibitor) medication Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 3: 1

Top Sponsors

  • Duke University1

Indications

  • Polyarticular Course Juvenile Idiopathic Arthritis (JIA)1
  • Arthritis1

San Francisco, California1 trial

Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis

University of California San Francisco Pediatric Rheumatology

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.